Serum Parameters of Iron Metabolism in Patients with Breast Cancer

Anticancer Research

Volumn 23, Issue 6 D, 2003, Pages 5107-5109

  Ulbrich, Eva Johanna ^a   Lebrecht, Antje ^a   Schneider, Ingeborg ^a   Ludwig, Elisabeth ^a   Koelbl, Heinz ^a   Hefler, Lukas A ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Anemia; Breast cancer; Ferritin; Receptor; Serum; Transferrin

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; ANEMIA; ARTICLE; BREAST CANCER; BREAST FIBROADENOMA; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INCIDENCE; IRON BLOOD LEVEL; IRON METABOLISM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSFERRIN BLOOD LEVEL;

ANEMIA; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL; FERRITINS; FIBROADENOMA; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; RETROSPECTIVE STUDIES; TRANSFERRIN;

EID: 0842321840     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Means RT and Krantz SB: Progress in understanding the pathogenesis of the anemias of chronic disease. Blood 80: 1639-1647, 1992.
2. Spivak JL: Cancer-related anemia: its causes and characteristics. Semin Oncol 21: 3-8, 1994.
3. Obermair A, Handisurya A, Kaider A, Sevelda P, Kolbl H and Gitsch G: The relationship of pretreatment serum hemoglobin level to survival of epithelial ovarian carcinoma patients: a prospective review. Cancer 83: 726-731, 1988.
4. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM and Madoc-Jones H: Prognostic factors for local and distant recurrence in stage I and II cervical cancer. Int J Radiot Oncol Biol Phys 32: 1309-1317, 1995.
5. Hefler I, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C and Tempfer C: Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumor Biol 21: 309-314, 2000.
6. Punnonen K, Irjala K and Rajamaki A: Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89: 1052-1057, 1997.
7. Skikne BS: Circulating transferrin receptor assay - coming of age. Clin Chem 44: 7-9, 1998.
8. Aapro MS: Adjuvant therapy of primary breast cancer: a review of key findings from the 7th International Conference, ST. Gallen, February 2001. Oncologist 6: 376-85, 2001.
9. Siedel J, Wahlefeld A and Ziegenhorn J: A new iron ferrozine reagent without deproteinization. Clin Chem 30: 97, 1984.
10. Fairbanks VF: Laboratory testing for iron status. Hospital Practice 26: 17-24, 1991.
11. Thomas I (ed): Labor und Diagnose. TH Books Verlagsgesellschaft mbH, Frankfurt/Main 1998.
12. Baynes RD: Assesment of iron status. Clin Biochem 29: 209-15, 1996.
13. Vaupel P and Hockel M: Blood supply, oxygenation status and metabolic micromelieu in breast cancer: Characterization and therapeutic relevance. Int J Oncol 17: 869-879, 2000.
14. Manegold C: The causes and prognostic significance of low hemoglobin levels in tumor patients. Strahlenther Onkol 174: 17-19, 1998.
15. Raaf HN, Jacobson DW, Savon S and Green R: Serum transferrin receptor level is not altered in invasive adenocarcinoma of the breast. Am J Clin Pathol 99: 232-237, 1993.
16. Ludwig H and Fritz E: Pathogenese und Therapie der therapie und tumorbedingten Anämie. In: Schmoll HJ, Hoffken K, Possinger K (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg, New York 2000, p 1579.
17. Yang DC, Wang F, Elliott RI and Head JF: Expression of transferrin receptor and ferritin H-chain mRNA associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res 21: 541-549, 2001.